Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Adage Capital Management, L.P. reported a 6.68% stake in Lexeo Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Adage Capital Management, L.P. reported a 6.68% stake in Lexeo Therapeutics, Inc., 2,209,615 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 6.68%
- Shares
- 2,209,615
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 6.68% | 2,209,615 |
| Robert Atchinson | 6.68% | 2,209,615 |
| Phillip Gross | 6.68% | 2,209,615 |
Source
Related
- Lexeo Therapeutics, Inc.
- Adage Capital Management, L.P.
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · May 12, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026